2001, Advocacy, Data and Sleep - Medical Cannabis Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2001

Advocacy

Data

Sleep

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12. This offers a more denotative approach to complement the data. Only one article appeared in the MJA in 2000 and again in 2001.

Research and Development

Research and Development Medicine Access Media

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space.

Research and Development

Research and Development Medicine Treatment Pharmaceutical

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Stay Connected